These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8152691)

  • 1. Dosimetric assessment of radiolabelled lipiodol as a potential therapeutic agent in colorectal liver metastases using combined CT and SPECT.
    Perring S; Hind R; Fleming J; Birch S; Batty V; Taylor I
    Nucl Med Commun; 1994 Jan; 15(1):34-8. PubMed ID: 8152691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution of Lipiodol following hepatic arterial injection.
    Hind RE; Loizidou M; Perring S; Fleming J; Batty V; Birch S; Taylor I
    Br J Surg; 1992 Sep; 79(9):952-4. PubMed ID: 1330198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of hepatocellular carcinoma with 131I-lipiodol: patient dosimetry.
    Risse JH; Pauleit D; Palmedo H; Bender H; Bucerius J; Ezziddin S; Klein V; Grünwald F; Biersack HJ; Reichmann K
    Nuklearmedizin; 2007; 46(5):192-7. PubMed ID: 17938753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient dosimetry for 131I-lipiodol therapy.
    Monsieurs MA; Bacher K; Brans B; Vral A; De Ridder L; Dierckx RA; Thierens HM
    Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):554-61. PubMed ID: 12690415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anti-tumoral activity of neoadjuvant intra-arterial 131I-lipiodol treatment for hepatocellular carcinoma: a pilot study.
    Brans B; De Winter F; Defreyne L; Troisi R; Vanlangenhove P; Van Vlierberghe H; Lambert B; Praet M; de Hemptinne B; Dierckx RA
    Cancer Biother Radiopharm; 2001 Aug; 16(4):333-8. PubMed ID: 11603004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of [131I]lipiodol as a hepatoma therapeutic agent.
    Lo JG; Wang AY; Wei YY; Lui WY; Chi CW; Chan WK
    Int J Rad Appl Instrum A; 1992 Dec; 43(12):1431-5. PubMed ID: 1334953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-arterial iodine 131-labeled lipiodol as adjuvant therapy after curative liver resection for hepatocellular carcinoma: a phase 2 clinical study.
    Partensky C; Sassolas G; Henry L; Paliard P; Maddern GJ
    Arch Surg; 2000 Nov; 135(11):1298-300. PubMed ID: 11074884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ablation of recurrent primary liver cancer using 131I-lipiodol.
    Novell R; Hilson A; Hobbs K
    Postgrad Med J; 1991 Apr; 67(786):393-5. PubMed ID: 1648718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective radionuclide localisation in primary liver tumours (pilot study).
    Novell JR; Green AJ; Hilson AJ; Dusheiko G; Dick R; Hobbs KE
    HPB Surg; 1994; 7(3):185-99; discussion 200. PubMed ID: 8155585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epirubicin-Lipiodol chemotherapy versus 131iodine-Lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma.
    Bhattacharya S; Novell JR; Dusheiko GM; Hilson AJ; Dick R; Hobbs KE
    Cancer; 1995 Dec; 76(11):2202-10. PubMed ID: 8635022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-arterial radionuclide therapy for liver tumours: effect of selectivity of catheterization and 131I-Lipiodol delivery on tumour uptake and response.
    Brans B; Bacher K; Vandevyver V; Vanlangenhove P; Smeets P; Thierens H; Dierckx RA; Defreyne L
    Nucl Med Commun; 2003 Apr; 24(4):391-6. PubMed ID: 12673167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver metastases from colorectal cancers: detection with CT during arterial portography.
    Matsui O; Takashima T; Kadoya M; Suzuki M; Hirose J; Kameyama T; Choto S; Konishi H; Ida M; Yamaguchi A
    Radiology; 1987 Oct; 165(1):65-9. PubMed ID: 2819942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. I-131-Lipiodol therapy in liver neoplasms.
    Risse JH; Grünwald F; Strunk H; Kleinschmidt R; Bender H; Biersack HJ
    Hybridoma; 1999 Feb; 18(1):83-5. PubMed ID: 10211793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraarterial HCC therapy with I-131-Lipiodol.
    Risse JH; Grünwald F; Kersjes W; Strunk H; Caselmann WH; Palmedo H; Bender H; Biersack HJ
    Cancer Biother Radiopharm; 2000 Feb; 15(1):65-70. PubMed ID: 10740654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic artery injection of I-131-labeled lipiodol. Part II. Preliminary results of therapeutic use in patients with hepatocellular carcinoma and liver metastases.
    Bretagne JF; Raoul JL; Bourguet P; Duvauferrier R; Deugnier Y; Faroux R; Ramée A; Herry JY; Gastard J
    Radiology; 1988 Aug; 168(2):547-50. PubMed ID: 2839867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nodular hepatocellular carcinoma. Treatment with subsegmental intraarterial injection of iodine 131-labeled iodized oil.
    Yoo HS; Lee JT; Kim KW; Kim BS; Choi HJ; Lee KS; Park CI; Park CY; Suh JH; Loh JJ
    Cancer; 1991 Nov; 68(9):1878-84. PubMed ID: 1717129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case report: localization of lipiodol-radioiodine in hepatic metastases from renal cell carcinoma.
    Stansby G; Bhattacharya S; Hilson AJ; Lane DM; Hobbs KE
    Br J Radiol; 1994 Aug; 67(800):822-4. PubMed ID: 8087492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid uptake and radiation dose after (131)I-lipiodol treatment: is thyroid blocking by potassium iodide necessary?
    Bacher K; Brans B; Monsieurs M; De Winter F; Dierckx RA; Thierens H
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1311-6. PubMed ID: 12271412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intrahepatic arterial infusion of 131I-labelled lipiodol on hepatocellular carcinoma of rat.
    Tsai C; Kusumoto Y; Harada R; Shima M; Nakata K; Kono K; Sato A; Ishii N; Koji T; Nagataki S
    Ann Acad Med Singap; 1986 Oct; 15(4):521-4. PubMed ID: 3032069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 131I-Labelled-iodized oil for palliative treatment of hepatocellular carcinoma.
    Borbath I; Lhommel R; Bittich L; Goffette P; Annet L; Van Beers BE; Bonny MA; Pauwels S; Horsmans Y
    Eur J Gastroenterol Hepatol; 2005 Sep; 17(9):905-10. PubMed ID: 16093866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.